IL6 and hepatocellular carcinoma: Further, biological-hypothesis-driven studies have identified several circulating protein biomarkers for HCC risk, including serum insulin-like growth factor I (IGF-I), osteopontin (OPN), and interleukin-6 (IL-6) [152,153,167].